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Cross-Linking the TCR Complex Induces Apoptosis in
CD4/8
/ Thymocytes in the Presence of Cyclosporin A
HEATHER L. POETSCHKE, DAVID B. KLUG, DAWN WALKER, and ELLEN R. RICHIE*
The University of Texas, M.D. Anderson Cancer Center, Science Park-Research Division, P.O. Box 389, Smithville, Texas 78957, USA
Although it is generally agreed that TCR ligation is a minimal requirement for negative
selection in the CD4/8 double-positive (DP) thymocyte subset, the costimulatory require-
ments and specific signaling events necessary to induce apoptosis are not well defined. We
have explored the consequences of cross-linkingCD3/TCR complexes on thymocytes from
H-Y TCR transgenic (Tg) mice. In agreement with previous reports, we demonstrate that
culturing DP thymocytes with plate-bound anti-TCR antibody induces downregulation of
CD4 and CD8 and upregulation of CD69 expression. Nevertheless, the activated cells did
not undergo apoptosis, as determined by viable cell recoveries and by quantitation ofDNA
fragmentation using the TUNEL assay. However, specific depletion of the DP subset oc-
curred within 24 hr when thymocytes were incubated in the presence of both anti-TCR and
the immunosuppressant cyclosporin A (CsA). CsA also induced depletion of anti-CD3
stimulated normalDP thymocytes. Using mice homozygous for the lpr or gld mutation, we
also have shown that Fas/Fas ligand interactions are not involved in the CsA-induced
death of TCR-stimulated DP thymocytes. These data verify that TCR cross-linking alone
is insufficient to induce apoptosis of DP thymocytes and further suggest that TCR stimu-
lation activates a CsA-sensitive protective pathway that interferes with signaling events
leading to apoptosis in DP thymocytes.
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INTRODUCTION
Intrathymic T-cell development is the consequence
of an orderly series of molecular events initiated by
contact between bone marrow derived precursors
and thymic stromal cells. Discrete stages of the
T-cell developmental process are defined pheno-
typically by expression ofCD4 and CD8 coreceptors
and the TCR/CD3 complex. Productive rearrange-
ment of the TCR chain locus is a prerequisite for
transition of immature CD4-8- double-negative (DN)
cells to the CD4/8 double-positive (DP) stage via a
CD4-81 intermediate (Nikolic-Zugic and Bevan,
1988; Mombaerts et al., 1992; Dudley et al., 1994).
Subsequent TCR0 gene rearrangement within the
DP subset results in low-level expression of0TCR/
CD3 complexes (Kearse et al., 1994). The process of
thymic selection operates on these TCR1 DP cells to
shape the final MHC-restricted TCR repertoire
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(Robey and Fowlkes, 1994). Positive selection refers
to the maturation of thymocytes expression TCRs
that mediate low-affinity interactions with self-
peptides presented by self-MHC molecules (Ashton-
Rickardt et al., 1994; Hogquist et al., 1994; von
Boehmer, 1994). The minor fraction of DP
thymocytes that undergoes positive selection differ-
entiates to either CD4-8 (MHC class I restricted)
or CD4/8 (MHC class II restricted) mature single-
positive (SP) cells that express high levels of TCR/
CD3 complexes. In contrast, DP thymocytes express-
ing TCRs with high affinity for self-MHC/self-
peptide complexes undergo clonal deletion, a pro-
cess referred to as negative selection (Fowlkes et al.,
1988; Kisielow et al., 1988; Ashton-Rickardt et al.,
1994). Because most DP thymocytes fail to express
TCRs that interact with self-MHC molecules, they
are neither positively nor negatively selected. These
"neglected" DP thymocytes have a short life span
(~3.5 days) in vivo and undergo apoptosis when
cultured in vitro (Robey and Fowlkes, 1994;
Kishimoto et al., 1995). Recently, direct evidence for2 H. POETSCHKE et al.
thymocyte apoptosis in situ was obtained using a
highly sensitive technique to detect DNA strand
breaks, i.e., terminal deoxynucelotidyl transferase
(TdT)-mediated labeling of nickedDNA with dUTP
biotin (TUNEL) (Surh and Sprent, 1994).
Although negatively selected and neglected
thymocytes undergo internucleosomal DNA frag-
mentation and morphological changes consistent
with apoptosis, the signal transduction pathways
and the role ofAPCs in promoting apoptosis are not
yet resolved. Several groups have demonstrated that
DP thymocytes expressing a transgenic TCR are
depleted when cultured in the presence of antigen
and APCs expressing appropriate MHC molecules
(Swat et al., 1991; Iwabuchi et al., 1992; Vasquez et al.,
1992). Cellular depletion also has been induced by
antibody-mediated ligation of the TCR/CD3 com-
plex. Anti-CD3 administered in vivo or in fetal thymic
organ cultures results in thymocyte death associated
withDNA degradation (Smith et al., 1989; Shi et al.,
1991). However, there are conflicting reports con-
cerning the requirement for APCs in anti-CD3-
induced apoptosis in vitro. Although some studies
conclude that antibody-mediated TCR cross-linking
alone is sufficient to stimulate DNA fragmentation
and/or cell death (McConkey et al., 1989a; Carlow
et al., 1992; Migita et al., 1994), other groups report
that anti-CD3-stimulated DP thymocytes fail to
undergo apoptosis in the absence ofAPCs, suggest-
ing that, in addition to TCR engagement, a second
signal is required fo induce apoptosis in the DP
subset (Page et al., 1993; Punt et al., 1994; Kearse
et al., 1995).
Regardless of whether one or two signals are re-
quired, it is generally agreed that negative selection
and anti-CD3-induced depletion of DP thymocytes
are active processes triggered by an endogenous
suicide mechanism. The apoptotic response of DP
thymocytes is induced by lower affinity TCR-
peptide/MHC interactions than are required to in-
duce proliferation of mature T cells (Vasquez et al.,
1994). Nevertheless, tyrosine kinase activation, el-
evated intracellular calcium levels, and PKC activa-
tion have been found necessary to achieve anti-TCR
or peptide/APC-induced apoptosis of DP thymo-
cytes (McConkey et al., 1994; Migita et al., 1994;
Vasquez et al., 1994). Even in the absence of bio-
chemical or morphological evidence of apoptosis,
triggering DP thymocytes through the CD3/TCR
complex induces phenotypic changes consistent with
cellular activation. Thus, TCR ligation effectively
reduces CD4 and CD8 levels while increasing CD5
and CD69 expression even when apoptosis is not
a consequence of cross-linking the TCR complex
(Page et al., 1993; Swat et al., 1993; Kearse et al., 1995).
These findings suggest that a TCR-mediated signal
transduction pathway is operative inDP thymocytes
regardless of whether the signal culminates inDNA
fragmentation and cell death.
In the present study, we utilized transgenic mice
expressing a TCR that is specific for the H-Y male
antigen presented by H-2b class I molecules to fur-
ther explore signal requirements for apoptosis inDP
thymocytes (Kisielow et al., 1988). The fraction of
transgenic CD4/8 cells containing fragmentedDNA
after incubation with anti-TCR0 chain antibodywas
quantitated using theTUNEL assay (Gorczyca et al.,
1993; Kishimoto et al., 1995). The data demonstrate
that TCR ligation induces downregulation of CD4
and CD8 as well as upregulation CD69 expression
in the absence of significant DNA fragmentation.
However, the addition of cyclosporin A (CsA) rap-
idly induces DNA fragmentation and depletion of
TCR-stimulated DP thymocytes. We suggest that
either CsA provides a second signal to induce
apoptosis in activated DP thymocytes or that TCR
signaling induces a CsA-sensitive protective path-
way that interferes with the manifestation of
apoptosis in the activated DP population. Prior ac-
tivation of the cells via in vivo engagement of the
transgenic TCR with self-MHC molecules is not
necessary because CsA depletes anti-TCR-activated
transgenic DP thymocytes from a nonselecting back-
ground as well as normal DP thymocytes activated
by anti-CD3 cross-linking. Furthermore, similar
experiments carried out with lpr and gld mutant mice
demonstrate that Fas/FasL interactions are not re-
sponsible for CsA-dependent depletion of TCR-
activated DP thymocytes.
RESULTS
Engagement of the TCR Induces Phenotypic
Changes but not DNA Fragmentation in
DP Transgenic Thymocytes
Thymocytes from female H-2b H-Y transgenic mice
were cultured for various intervals in the presence
or absence of plate-bound anti-TCR( chain antibody
(T3.70) to determine whether signaling through the
TCR alone could induce phenotypic alterations and/
or apoptosis. TCR ligation did not result in signifi-
cant thymocyte depletion at 24 hr. In seven experi-APOPTOSIS IN TCR-STIMULATED THYMOCYTES 3
ments, the recovery of viable cells after incubation
in antibody-coated wells ranged from 72 to 100% of
the cells obtained following incubation in medium
alone. Furthermore, there was no difference in the
percentage of antibody treated versus untreated cells
falling within a viable cell gate defined by forward
and 90 light-scattering properties. To determine the
effect ofTCR cross-linking on surface marker expres-
sion, immunofluorescence (IF) profiles were ob-
tained, and the results of a representative experiment
are shown in Fig. 1A. Consistent with previous re-
ports (Page et al., 1993; Kearse et al., 1995), TCR
ligation induced a marked decrease inCD4 and CD8
expression on the DP subset. CD4 and CD8 down-
regulation was detectable as early as 6 hr and ex-
pression continued to decrease at later time points.
To further characterize the effect of TCR ligation on
the DP subset, the expression of CD69, an early ac-
tivation marker, was evaluated on DP cells defined
by the electronic gate shown in Fig. 1A. CD69 sur-
face expression was upregulated by anti-TCR stimu-
lation within 6 hr. By 24 hr >70% of the DP subset
expressed CD69, suggesting that cross-linking the
CD3/TCR complex transduces activation signals in
the majority of DP thymocytes.
Although there is general agreement that stimu-
lation of DP thymocytes with antigen and APCs
induces DNA fragmentation and apoptosis, the
consequences of antibody-mediated ligation with
anti-TCR antibody in the absence of APCs are con-
troversial (McConkey et ai., 1989a; Carlow et al.,
1992; Page et al., 1993; Migita et al., 1994; Punt et al.,
1994; Kearse et al., 1995). To further explore this is-
sue, we employed theTUNEL assay, which has been
shown to be more sensitive than other methods for
detection of DNA fragmentation (Kishimoto et al.,
1995). Thymocytes recovered 24 hr after incubation
in the presence or absence of T3.70 antibody were
stained for CD4 and CD8 surface markers and sub-
sequently fixed for nucleotide incorporation in the
presence (or absence) of TdT. The data in Fig. 1B
reflect b-dUTP incorporation in DP thymocytes
using the same gates for CD4/8 cells shown in
Fig. 1A. By 24 hr, after incubation in medium alone,
27% of the control cells incorporated b-dUTP, a find-
ing consistent with the report of Kishimoto and col-
leagues in which the TUNEL method was used to
quantitate apoptosis in nonstimulated thymocyte
cultures (Kishimoto et al., 1995). Similarly, 24% of
the DP thymocytes incorporated b-dUTP after incu-
bation in the presence of plate-bound T3.70 antibody.
Taken together, the data in Fig. 1 suggest that
although DP thymocytes are signaled via TCR
ligation to express an altered profile of cell-surface
markers, this activation pathway does not extend to
induction of DNA fragmentation, a hallmark of
apoptosis.
CsA Inhibits CD69 Expression and Induces
DNA Fragmentation and Cellular Depletion
in TCR-Stimulated Transgenic DP Thymocytes
CsA is an immunosuppressive drug that inhibits
mature T-cell activation (Schreiber and Crabtree,
1992). CsA is thought to act by binding to its cyto-
solic receptor, cyclophilin, to form a complex
that inhibits the activation of the calcium- and
calmodulin-dependent serine/threonine phospha-
tase, calcineurin. To determine if CsA affects T3.70-
mediated activation of DP thymocytes, H-2b H-Y
transgenic thymocytes were incubated in the pres-
ence or absence of plate-bound T3.70 antibody, and
100 ng/ml of CsA was added to selected cultures at
initiation. In preliminary titration experiments, con-
centrations of CsA ranging from 10 ng/ml to I tg/
ml gave similar results in the presence or absence of
antibody. Fig. 2 shows surface marker expression on
thymocytes recovered at various intervals. The ad-
dition of CsA had no effect on DP thymocytes incu-
bated in the absence of T3.70 antibody. However,
inclusion of CsA in T3.70-stimulated cultures re-
sulted in a dramatic decrease in the percentage of
DP cells recovered at 24 hr. In addition, CsA inhib-
ited the appearance of CD4181 cells and induction
ofCD69 expression, phenotypic alterations that were
consistently observed after TCR cross-linking in the
absence of CsA. These data suggest that CsA effec-
tively depletes TCR-stimulated DP thymocytes.
Table I presents the percentage and absolute number
of thymocytes recovered in each of the four major
thymocyte CD4/8 subsets after incubation in the
presence or absence of plate-bound antibody and
CsA. Although the decreased percentage ofDP cells
is partially compensated forby an increased percent-
age of cells in the DN and SP compartments, the
absolute number of cells recovered in each subset
shows that cellular depletion is restricted primarily
to the DP subset. The absence of a CD418I popula-
tion may, as Kearse and colleagues assert, indicate
that CsA inhibits downregulation prior to CsA-
induced DP death or rapid depletion following
coreceptor downregulation.
To determine if the depletion of activated DP
thymocytes was a consequence of apoptosis, the4 H. POETSCHKE et al.
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FIGURE 1. Antibody-mediated cross-linking of theTCR complex onDP thymocytes induces phenotypic alterations in the absence
of DNA fragmentation. Thymocytes from female H-2 H-Y TCR transgenic mice were incubated with plate-bound T3.70 antibody
for the indicated time intervals. (A) Three-color IF analysis of CD4, CD8, and CD69 expression. CD4/8 cells falling within the
indicated electronic gates were assessed for CD69 expression. The histogram shows CD69 expression on DP cells incubated in
media (broken line) or with anti-TCR antibody (dark solid line). The lighter solid line shown only in the uppermost histogram
represents CD69 expression on DP thymocytes prior to culture. The percentage of CD69-positive cells induced by anti-TCR stimu-
lation are shown. (B) DNA fragmentation was determined by the percentage of cells that incorporated b-dUTP in the TUNEL assay
performed in the presence of TdT. Controls stained in the absence of TdT showed <2% b-dUTP incorporation (data not shown). The
percentage of TUNEL-positive cells after 24 hr incubation are shown.APOPTOSIS IN TCR-STIMULATED THYMOCYTES 56 H. POETSCHKE et al.
TABLE
Recovery of Thymocyte Subsets after Anti-CD3-Stimulation in the Presence or Absence of CsA
Number (x10-5) Percentage
Ab CsA DN DP CD4 CD8 DN DP CD4 CD8
Exp.
Exp. 2
2.1 8.7 0.8 0.4 16 65 6 3
+ 2.8 11 1.2 0.6 17 65 7 4
+ 2.0 8.9 0.6 0.3 16 72 5 2
+ + 1.6 1.6 0.6 0.2 36 37 13 4
ND ND ND ND ND ND ND ND
+ 1.3 12 0.8 1.0 8 77 5 6
+ 1.7 10 0.6 1.0 12 74 4 7
+ + 3.3 1.7 1.4 4.0 45 23 19 6
After 24 hr, the number of viable cells determined by trypan blue dye exclusion. CD4/8 subset distribution determined cells that stained with CD4-PE
and CD8-FITC. The number of cells in each subset calculated by multiplying the total number of viable cells recovered by the percentage of cells in each phenotypic
subset.
ND not determined.
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FIGURE 3. CsA induces apoptosis in anti-TCR-stimulated DP thymocytes from female H-2 H-YTCR transgenic mice. Thymocytes
from female H-2 H-Y TCR transgenic mice were incubated for the indicated intervals in the presence or absence of plate-bound
T3.70 antibody. CsA (100 ng/ml) was added as indicated to selected cultures. TUNEL staining of electronically gated DP cells was
determined by b-dUTP incorporation in the presence of TdT.APOPTOSIS IN TCR-STIMULATED THYMOCYTES 7
TUNEL assay was performed. The data in Fig. 3
show that as expected, cells incubated in the pres-
ence of T3.70 or CsA alone did not show a substan-
tial increase in b-dUTP incorporation above that
observed in media controls. In contrast, b-dUTP
incorporation was substantially increased by 6 to
12 hr in DP thymocytes cultured in the presence of
both T3.70 and CsA, and by 24 hr, >80% of the
remaining DP cells contained fragmented DNA.
Notably, CsA failed to cause DNA fragmentation in
the T3.70 or anti-CD3-stimulated DN and SP sub-
sets (data not shown). These data demonstrate that
DP thymocytes from H-Y TCR transgenic H-2b mice
undergo apoptosis when incubated in the presence
of plate-bound anti-TCR antibody and the immu-
nosuppressant CsA.
H-2d H-Y Transgenic and Normal
DP Thymocytes Undergo Apoptosis after
Stimulation via the TCR/CD3 Complex in
the Presence of CsA
The previous experiments were carried out with
female H-2b H-Y transgenic mice in which develop-
ing thymocytes are subject to positive selection. To
address the possibility that the consequences of in
vitro TCR ligation were due, in part, to previous
engagement between the transgenicTCR and select-
ing H-2b molecules in vivo, similar studies were car-
ried out with H-2d H-Y transgenic mice in which
positive selection of the Ff-Y TCR does not occur
because the appropriate restrictingMHC allele is not
present. As in the H-2b background, DP thymocytes
from H-2d transgenics respond to TCR ligation by
downmodulating CD4 and CD8 surface levels and
inducing CD69 expression (Table 2 and data not
shown). Although the H-2d transgenics incorporated
high background levels of d-UTP, TCR ligation in-
duced little, if any, DNA fragmentation above that
observed in unstimulated cells. TCR ligation in the
presence of CsA reduced the percentage and abso-
lute number of H-2d transgenic DP cells, and the
majority of DPs that were not deleted by 24 hr
failed to express CD69 and contained fragmented
DNA (Table 2 and data not shown). Likewise, DP
thymocytes from normal C57B1/6J mice were acti-
vated in response to anti-CD3-mediated TCR cross-
linking, as revealed by downregulation of CD4 and
CD8 and upregulation of CD69. The addition ofCsA
to antibody-stimulated cultures reduced the percent-
age of cells in the DP compartment, inhibited CD69
expression and augmented b-dUTP incorporation in
the remainingDP cells (Table 2 and data not shown).
Interestingly, the percentage of TUNEL positive
cells is generally lower in normal versus H-2d H-Y
transgenic thymocytes. This phenomenon was also
observed when normal thymocytes were compared
with H-2b transgenic thymocytes that had relatively
low background levels of b-dUTP incorporation
(Fig. 3). Although the basis for this distinction be-
tween normal and transgenic thymocytes requires
further investigation, the results for H-2d transgenic
and normal thymocytes demonstrate that alterations
in surface marker phenotype and susceptibility to
CsA-induced apoptosis are solely a consequence of
TCR engagement in vitro and not a consequence of
previous in vivo signal transduction events.
CsA-Induced Apoptosis Is Not a Function
of Fas/FasL Interactions
The Fas cell surface receptor, a member of the tumor-
necrosis factor receptor family, induces apoptosis of
TABLE 2
Response of DP Thymocytes from H-Y H-2 Transgenic and Normal Mice to TCR Ligation in the Presence or Absence of CsA
Percentage of CD69 Cells Percentage of Cells Incorporating b-dUTP
Cells Exp. Control CsA Ab CsA+Ab Control CsA Ab CsA+Ab
H-2 H-Y
Transgenic
Normal
C57B1/6
8 6 77 19 ND ND ND ND
2 ND ND ND ND 37 41 38 89
3 5 4 64 14 30 46 35 81
4 5 4 68 16 37 41 53 82
1 5 5 53 7 ND ND ND ND
2 ND ND ND ND 22 30 29 51
3 ND ND ND ND 16 20 22 40
4 5 5 65 21 18 20 22 41
Thymocytes incubated for 24 hr in the presence absence of plate-bound anti-CD3. CsA (100 ng/ml) added to selected cultures at initiation. The recovered cells
stained with anti-CD4-PE, anti-CD8-FITC, and either anti-CD69-biotin fixed for the TUNEL assay, described in Materials and Methods. CD69 expression and
b-dUTP incorporation presented for gated DP thymocytes.
ND not determined.8 H. POETSCHKE et al.
activated T cells upon interaction with its ligand,
FasL. Recently, it was reported that DP thymocytes
not only express Fas, but also undergo apoptosis in
the presence of anti-Fas antibody (Ogasawara et al.,
1995).We utilized the mutant lprmouse strain, which
is deficient in Fas expression (Watanabe-Fukkunaga
et al., 1992), as well as the mutant gld (Takahashi
et al., 1994) mouse strain, which is deficient in FasL
expression, to investigate whether CsA-induced
apoptosis of TCR-stimulated DP thymocytes is a
function of Fas/FasL interaction. Both lpr and gld
DP thymocytes are activated by Ab-mediated cross-
linking of cell surfaceCD3 to downregulateCD4 and
CD8 and upregulate CD69 (Fig. 4 and data not
shown). In addition, activated lpr and gld DP
thymocytes undergo apoptosis in the presence of
CsA. The percentage of DPs containing fragmented
DNA in the mutant strains is similar to that observed
in thymocytes from normal mice. An earlier report
showing that CsA inhibits activation-induced ex-
pression of FasL (Dhein et al., 1995) supports these
findings and indicates that induction of FasL expres-
sion and interaction with the Fas receptor are not
responsible for CsA-mediated apoptosis in TCR-
activated thymocytes.
Cycloheximide Inhibits Anti-TCR-Induced
Phenotypic Alterations and CsA-Induced
Apoptosis
Previous studies have shown that activation-induced
cell death in thymocytes and T-cell hybridomas
is an active process that is inhibited by CHX
(McConkey et al., 1989b; Ucker et al., 1989; Vasquez
et al., 1992, 1994). To determine if CsA-induced
apoptosis of activated thymocytes is similarly de-
pendent on protein synthesis, CHX was included in
thymocyte cultures in the presence or absence of
plate-bound anti-CD3 and CsA. The recovered cells
were evaluated for surface marker expression and
incorporation ofb-dUTP in the TUNEL assay. There
was no toxicity associated with the concentration of
CHX (20 Bg/ml) used in these experiments, although
minimal toxicity was observed at higher concentra-
tions (40 Bg/ml). CHX alone affected neither the
surface phenotype nor the percentage of TUNEL
CsA
anti
CD3
anti
CD3 +
CsA
A. Lpr B. GId
b dUTP
FIGURE 4. CsA-induced apoptosis of TCR-activated thymocytes is not a function of the Fas/FasL interaction. Thymocytes ob-
tained from (A) lpr or (B) gld mice were stimulated with anti-CD3 for 24 hr in the presence or absence of CsA. In addition to
assessment of CD4/8 profiles, DNA fragmentation in electronically gated DP cells was assessed by the percentage of cells that
stained positive in the TUNEL assay.APOPTOSIS IN TCR-STIMULATED THYMOCYTES 9
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FIGURE 5. Effect ofCHX on the surface marker alterations and DNA fragmentation induced by TCR ligation in the presence and
absence of CsA. Thymocytes from female H-Y H-2 transgenics were cultured with plate-bound (A) T3.70 or (B) anti-CD3. CsA
and/or CHX (20 tg/ml) were added to selected wells at initiation. CD69 expression and TUNEL reactivity were determined on the
gated DP subset. The percentage of cells within the indicated DP gate was 66% with CHX, 67% with CHX + CsA, 49% with anti-
TCR, 66% with anti-TCR + CHX, 20% with anti-TCR + CsA, and 66% with anti-TCR + CHX + CsA.10 H. POETSCHKE et al.
positive thymocytes. However, the data in Fig. 5
show that CHX completely abrogated antibody-
induced upregulation of CD69 on the DP subset.
Interestingly, CHX treatment also prevented the
downregulation of CD4 and CD8 that characteristi-
cally accompanies TCR ligation of DP cells. Similar
results were obtained with 10 tg/ml of CHX (data
not shown). Furthermore, CHX treatment pro-
foundly inhibited CsA-induced apoptosis of TCR-
activated DP thymocytes. When CHX was also
included in cultures containing anti-TCR plus CsA,
there was no reduction in the percentage of cells in
the DP compartment. In addition, the DP cells ob-
tained from these cultures failed to incorporate
b-dUTP beyond control levels. Taken together, the
data demonstrate that anti-CD3-induced CD4 and
CD8 downregulation as well as CD69 upregulation
require active protein synthesis as does the apoptotic
response that occurs whenDP thymocytes are stimu-
lated with anti-TCR in the presence of CsA.
DISCUSSION
The present investigation has examined the conse-
quences of cross-linking the TCR complex on DP
thymocytes from transgenic and normal mice. We
found that antibody-mediated TCR ligation results
in downregulation ofCD4 and CD8 levels as well as
induction of CD69 expression but stimulates mini-
mal, if any, DNA fragmentation or cellular deple-
tion above that observed in unstimulated cells.
Nevertheless, stimulation via the TCR activates a
potentially apoptotic pathway in DP thymocytes
because the addition of CsA to anti-TCR-activated
thymocytes induces rapid apoptosis detected by
DNA fragmentation and cellular depletion.
Thymocytes that are incubated with CsA in the ab-
sence of anti-TCR antibody do not undergo cellular
activation or apoptosis. Therefore, CsA-mediated
induction of apoptosis in the DP subset is depend-
ent upon signal transduction events that result from
cross-linking the TCR complex.
There have been conflicting reports concerning the
effect of CsA on negative selection in vivo and
thymocyte deletion in vitro. Similar to the results
presented here, two other groups have shown that
CsA augments the deletion of thymocytes activated
in vitro by anti-CD3 or phorbol ester plus ionophore
(McCarthy et al., 1992; Cairns et al., 1993; Curnow
and Schmitt-Verhulst, 1994). However, in apparent
conflict with these results, in vivo administration of
CsA is reported to inhibit depletion of normal
thymocytes that express self-reactive TCRs (Gao
et al., 1988; Jenkins et al., 1988) and to delay nega-
tive selection in H-YTCR transgenic H-2b male mice
(Urdahl et al., 1994). This apparent discrepancymay
be due to the fact that CsA not only adversely
affects lymphocyte activation, but also inhibits ac-
cessory cell function. In this regard, CsA treatment
of splenicAPCs inhibits their costimulatory activity
in vitro (Cairns et al., 1993), and ultrastructural stud-
ies show that CsA damages thymic reticulo-
epithelial cells in vivo (Fabien et al., 1992). Therefore,
CsA-mediated blockade of negative selection in vivo
may be an indirect consequence of interference with
the costimulatory activity of thymic APCs. Another
factor that is likely to affect the outcome of CsA
treatment and to reconcile some of the contradict-
ory findings is the maturation stage of the target
cells. For example, the addition of CsA to mature
T-cell hybridomas has been repeatedly shown to
block DNA fragmentation in vitro (Shi et al., 1989;
Zacharchuck et al., 1990). In contrast, other stud-
ies have reported that CsA fails to inhibit TCR-
mediated activation-induced apoptosis in cultures
of immature DP thymocytes (Anderson et al., 1995;
Wang et al., 1995). It seems likely that differences in
the signaling pathways activated byTCR ligation in
mature versus immature T cells contribute to the
opposing conclusions reached in prior reports con-
cerning the effect of CsA on activation-induced
apoptosis. Finally, it should be emphasized that
because apoptosis is maximally induced whenTCR-
activated thymocytes are incubated in the presence
of costimulatory signals (Iwabuchi et al., 1992; Page
et al., 1993; Punt et al., 1994), the potentiating effect
of CsA on DNA fragmentation is not apparent un-
der these conditions. Wang and colleagues reported
that although CsA inhibits positive selection, it
fails to inhibit DNA fragmentation induced in
thymocytes by anti-TCR or superantigen in the pres-
ence of accessory cells (Wang et al., 1995). This con-
clusion does not conflict with our data showing that
in the absence of costimulation, CsA potentiates
apoptosis in TCR-activated thymocytes.
There are at least two possible interpretations of
the results obtained in this investigation: (1) TCR
ligation not only triggers molecular events that can
culminate in apoptosis, but also induces a CsA-
sensitive pathway capable of blocking activation-
induced DNA fragmentation and cell death; and (2)
CsA provides a second signal that in combination
with signals generated by TCR cross-linking resultsAPOPTOSIS IN TCR-STIMULATED THYMOCYTES 11
in apoptosis. In this first scenario, TCR-mediated
activation of DP cells in the absence of CsA would
result in molecular events that confer protection
against a TCR-induced cellular suicide process. CsA
treatment would inhibit an essential component of
the protective pathway, thereby permitting the cells
to undergo activation-induced apoptosis. In the
second scenario, a signal transduction process
initiated by the TCR would combine with a sep-
arate CsA-derived signal to induce apoptosis.
Although the present data do not distinguish be-
tween these two possibilities, we favor the former
explanation because CsA is known to inhibit T cell
activation events. CsA exerts its immunosup-
pressive activity by inactivating calcineurin, a cal-
cium- and calmodulin-dependent serine/threonine
phosphatase (Schreiber and Crabtree, 1992). Cal-
cineurin activity is required for activation of NF-AT
and expression of c-rel, two DNA-binding proteins
that regulate transcription of IL-2 and IL-2-receptor
0-chain genes, respectively (McCaffrey et al., 1993;
Venkataraman et al., 1995). Perhaps calcineurin ac-
tivates transcription factors that regulate genes,
encoding proteins that inhibit DNA fragmentation,
thereby protecting activated DP thymocytes from
undergoing apoptosis. Inactivation of calcineurin
by CsA could result in abrogation of this protect-
ive pathway, permitting apoptosis to proceed. Al-
ternatively, calcineurin is also known to affect other
targets including substrates of cAMP-dependent
kinases (Cohen, 1989).
Previous reports have shown that stimulation of
normal thymocytes withPMA or calcium ionophore
inducesDNAfragmentation, whereas costimulation
with appropriate concentrations of both reagents
fails to do so (Kizaki et al., 1989; McCarthy et al.,
1992; Cairns et al., 1993) The addition ofCsA toPMA
plus ionophore-treated thymocytes reverses the
protective effect, resulting in increased DNA frag-
mentation (McCarthy et al., 1992; Cairns et al., 1993).
These observations suggest that apoptosis is a po-
tential consequence of either PKC activation or in-
creased intracellular calcium concentration, but that
DNA fragmentation is inhibited by an active pro-
cess induced by a combination ofPKC and calcium-
mediated signals. Although the effect ofTCR ligation
on surface marker expression was not determined,
the same report showed that CsA-induced apoptosis
induced in thymocytes incubated with plate-bound
anti-CD3 antibodies (Cairns et al., 1993). However,
the extent ofDNAfragmentation was low compared
to our data, an inconsistency that is likely due to the
greater sensitivity of the TUNEL assay used in the
present investigation. Based on the currentwork and
previous reports cited above, we suggest that trig-
gering DP thymocytes via TCR ligation activates a
signal transduction pathway(s) similar to that in-
duced by coincubation with PMA and ionophore,
implying that both PKC and calcium play a role in
the anti-CD3-induced pathway that prevents mani-
festation of activation-induced apoptosis. Further-
more, the apoptotic pathway that is stimulated in
DP thymocytes by TCR ligation in the presence of
CsA requires protein synthesis, as demonstrated
by the finding that CHX effectively blocks DNA
fragmentation.
In keeping with the notion that mature and im-
mature thymocytes are distinguished in part by
variations in signal transduction circuitry, it is in-
teresting to note that, as in the DP subset, CsA
prevented anti-TCR-induced CD69 expression on
mature CD4-8 thymocytes from H-Y transgenic
mice (data not shown). Nevertheless, in contrast to
the DP subset, the CD4-8 subset was resistant to
apoptosis induced by stimulation via the TCR in the
presence of CsA. Similar results were obtained for
normal SP thymocytes stimulated with anti-CD3 in
the presence or absence of CsA. These data suggest
that as thymocytes undergo intrathymic maturation,
TCR ligation fails to trigger the same apoptotic
pathway that is induced in the DP subset or that
the protective factor(s) preventing TCR-stimulated
apoptosis is constitutively produced and not sub-
ject to CsA-mediated repression. In this regard, it will
be interesting to determine if members of the bcl-2
family play a role in this process because bcl-2
has been shown to inhibit apoptosis induced in
thymocytes by a variety of agents, including radia-
tion, glucocorticoids, and in vivo injection of anti-
CD3 (Sentman et al., 1991; Strasser et al., 1991; Siegel
et al., 1992). Another molecular mechanism that is
associated with activation-induced cell death in
thymocytes is the signal transduction pathway in-
duced by Fas/FasL interaction. Since anti-Fas anti-
body induces DNA fragmentation and cell death in
DP thymocytes (Ogasawara et al., 1995), it was of
interest to determine if anti-TCR plus CsA-induced
apoptosis in DP thymocytes was a function of sig-
nals transduced via the Fas receptor. The data
showing that CsA induces DNA fragmentation in
anti-CD3-stimulated Ipr and gld DP thymocytes
clearly demonstrate that Fas/FasL interaction does
not play a role in the CsA-induced apoptosis of ac-
tivated DP thymocytes. However, the possibility12 H. POETSCHKE et al.
remains that CsA-induced death of TCR-activated
DP cells mimics the signal transduction events
downstream of the Fas/FasL interaction.
Cross-linking the TCR complex by plate-bound
antibody induced CD69 expression on the majority
ofTCR transgenic DP thymocytes from nonselecting
H-2d mice as well as on DP thymocytes from normal
mice, suggesting that in contrast to a previous inter-
pretation (Swat et al., 1993), the TCR-activation path-
way is coupled to inducibility of CD69 expression
prior to positive selection. The present data also
demonstrate that upregulation of CD69 expression
and downregulation ofCD4 and CD8 expression are
achieved by TCR ligation in the absence of addi-
tional signaling events. However, there is continu-
ing controversy concerning the issue of whether a
second signal, in addition to TCR cross-linking, is
required for induction of apoptosis inDP thymocytes
(McConkey et al., 1989a; Carlow et al., 1992; Page
et al., 1993; Migita et al., 1994; Punt et al., 1994; Kearse
et al., 1995). The present data support the notion
that TCR ligation alone is insufficient to stimulate
activation-induced DNA fragmentation in DP
thymocytes. APCs have been shown to effectively
provide costimulatory signals that induce dele-
tion of antigen or anti-TCR-activated thymo-
cytes (Iwabuchi et al., 1992; Page et al., 1993).
Costimulation is thought to be supplied by interac-
tion between APC surface ligands and correspond-
ing receptors expressed on activated thymocytes. We
demonstrate in this report that CsA can efficiently
replace the requirement for APCs in achieving
DNA fragmentation in anti-TCR-stimulated DP
thymocytes. It is possible that APCs and CsA sim-
ilarly affect signaling pathways that result in
apoptosis. If so, then the function of APCs may not
be to provide a second signal that generates novel
molecular events required for apoptosis, but instead
to provide a second signal that interferes with a
TCR-activated protective pathway that prevents
activation-induced apoptosis.
Although both normal and transgenic thymocytes
are susceptible to apoptosis induced by stimulation
with plate-bound anti-TCR in the presence of CsA,
there was a consistent difference in the percentage
of DP cells containing fragmented DNA 24 hr
after culture initiation. The TCR transgenic DP
thymocytes were almost uniformlyTUNEL positive,
whereas a significant fraction of normal DP
thymocytes remained TUNEL negative. This phe-
nomenon was observed regardless of whether the
transgenic thymocytes were obtained from a select-
ing or nonselecting MHC haplotype. The nature of
the resistant DP subset from normal mice was not
determined, but we surmise that these cells may be
defective in TCR-mediated signal transduction be-
cause they (1) represent cells that have not yet en-
tered the apoptotic path.way (delayed kinetics), and/
or (2) represent early DPs that express low levels of
CD3/TCR complexes precluding efficient signal
transduction, and/or (3) represent cells that have
not yet coupled surface CD3/TCR complexes to
appropriate intracellular signaling pathways. It was
not possible to adequately assess the first possi-
bility because initial attempts to culture normal
thymocytes for 48 hr yielded a high level of non-
specific cell death in the absence of anti-CD3. To
address the second possibility, we evaluated the
response of DP thymocytes from mice homozygous
for a mutant TCR0 gene (TCR-/-) because these
cells express extremely low levels of cell surfaceCD3
(Mombaerts et al., 1992; Philpott et al., 1992). Cross-
linking CD3 complexes with plate-bound anti-CD3
not only fails to induce characteristic phenotypic
changes in the TCR0c/-DP thymocytes, but also fails
to induceDNAfragmentation in the presence ofCsA
(data not shown). However, it is not possible to dis-
tinguish if the lack of responsiveness to anti-CD3
cross-linking is due to low levels of CD3 expres-
sion and/or to differences in the composition of
CD3 complexes on TCR0-/- compared to normal
thymocytes. Therefore, further studies are required
to define the nature of the TUNEL negative normal
DP thymocytes that resist anti-CD3 plus CsA-
induced apoptosis.
In summary, this report verifies that although
antibody-mediated cross-linking of the CD3/TCR
complex on DP thymocytes activates a signal
transduction pathway resulting in altered surface
marker expression, TCR ligation alone is insufficient
to induce apoptosis in the DP subset. However,
H-Y TCR transgenic as well as normal DP thymo-
cytes are subject to rapid apoptosis when CD3/TCR
complexes are cross-linked in the presence of CsA.
These data suggest the existence of a CsA-sensitive
protective pathway that prevents TCR-stimulated
DNA fragmentation. By using the experimental
model described in this report, it is now possible to
investigate specific components of the signal trans-
duction pathway(s) that alter expression of dif-
ferentiation antigens and that expedite or inhibit
activation-induced cell death in DP thymocytes.APOPTOSIS IN TCR-STIMULATED THYMOCYTES 13
MATERIALS AND METHODS
Mice
Breeding pairs of H-2b H-Y TCR transgenic mice
(Kisielow et al., 1988) and H-2d H-Y TCR transgenic
mice were kindly supplied by Dr. Dan Littman (De-
partment of Microbiology and Immunology, Univer-
sity of California San Francisco) and Dr B.J. Fowlkes
(National Institutes of Health, Bethesda, MD), re-
spectively. C57BL/6J, TCR0ff-/-), lpr and gld mice
were purchased from Jackson Laboratories (Bar
Harbor, ME). All mice were bred and/or maintained
in accordance with institutional guidelines in the
animal facility at the M.D. Anderson Science Park
Research Division.
Preparation and Culture of Thymocytes
Single-cell suspensions were prepared from thy-
muses of 4-8 week-old mice by pressing the tissue
through a nylon mesh into cold 5 mM HEPES-
buffered Hank’s balanced salt solution (HBSS) con-
taining 1% bovine serum albumin, pH 7.4. After
washing, the cells were resuspended in RPMI 1640
media supplemented with 55 gM 2-ME, 2 mM L-
glutamine, 1 mM sodium pyruvate, 1 mM non-
essential amino acids (Gibco BRL, Grand Island, NY),
and 10% FCS (Summit Biotechnology, Greeley, CO),
and distributed at 1-2.5 x 106/ml in 24-well tissue-
culture plates. The wells were pretreated with HBSS
buffer or 10-20 gg of appropriate mAb for 3 hr or
overnight at 37C and washed three times with
buffer before use. After incubation at 37C, 5% CO
for various intervals, cells were recovered by
washing the wells three times with HBSS buffer.
Cyclosporin A (CsA), (Sandoz, East Hanover, NJ)
was used at a final concentration of 100 ng/ml.
Cycloheximide (CHX) (Sigma, St. Louis, MO) was
used at a concentration of 20 gg/ml.
Antibodies, Immunofluorescence, and
Flow Cytometry
PE-conjugated anti-CD4 (clone RM4-5), FITC-
conjugated anti-CD8 (clone 53-6.7), and biotin-
ylated anti-CD69 (clone H1.2F3) were obtained from
PharMingen (San Diego, CA). Anti-CD3 (500A) and
anti-Vc3 (T3.70) were purified from hybridoma cul-
ture supernatant using protein A or protein G col-
umns. Cells for three-color immunofluorescence
analysis were suspended in HBSS containing 1%
BSA and 0.1% sodium azide and incubated with
directly conjugated antibodies on ice for 30 min fol-
lowed by three washes to remove excess reagents.
To detect binding of biotinylated antibody, the cells
were incubated with allophycocyanin-conjugated
strepavidin (APC-SA) (Molecular Probes, Eugene,
OR) for 15 min on ice followed by additional washes
and fixation in 1% paraformaldehyde. Stained cells
were analyzed with a Coulter Epics Elite flow cy-
tometer (Miami, FL) equipped with an argon laser
(488 nm) for FITC and PE excitation and a helium
neon laser (633 nm) for APC-SA excitation. Data
were collected on 10-20 x 103 viable cells using a four-
decade log amplifier and stored in list mode for
subsequent analysis using Coulter Elite software.
Immunofluorescence and TUNEL profiles were re-
stricted to cells that fell within a viable gate esta-
blished by forward and 90 light-scatter profiles.
TUNEL Assay
The terminal dexoynucleotidyl transferase (TdT)-
mediated dUTP-biotin nick end labeling (TUNEL as-
say) reaction was performed according to Kishimoto
et al. 1995 with certain modifications. Thymocytes
that had been surface stained forCD4 and CD8 were
fixed in 1% paraformaldehyde followed by 70%
ethanol at4C for 15 min each. After two washes in
HBSS, the pellet was resuspended in TdT buffer
(200 mM potassium cacodylate, 25mM Tris-HC1,
250 gg/ml BSA) plus 2.5 mM cobalt chloride,
0.02 nM biotin-16-dUTP (b-dUTP), and 0.5 U/gl TdT
(Boehringer Mannhein, Indianapolis, IN). Cells were
incubated in the absence of TdT as a negative con-
trol. After incubation at 37C for 30 min, the cells
were washed twice with HBSS containing 1% BSA
and 0.1% sodium azide. TdT-dependent incorpora-
tion of dUTP-biotin was visualized byAPC-SA stain-
ing for 30 min on ice.
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